Jong R. Eun
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Overview of hepatocarcinogenesis focusing on cellular origins of liver cancer stem cells: a narrative review.
Journal: Journal of Yeungnam medical science
Published: September 22, 2024
Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease.
Journal: Gut and liver
Published: July 02, 2024
Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology.
Journal: Yeungnam University journal of medicine
Published: March 20, 2019
Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway.
Journal: PloS one
Published: July 26, 2018
CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates.
Journal: Stem cells and development
Published: July 21, 2015
Clonogenically Culturing and Expanding CD34+ Liver Cancer Stem Cells in Vitro.
Journal: Stem cells and development
Published: April 14, 2015
Identification of cancer stem cell subpopulations of CD34(+) PLC/PRF/5 that result in three types of human liver carcinomas.
Journal: Stem cells and development
Published: December 19, 2014
Cilostazol Decreases Ethanol-Mediated TNFalpha Expression in RAW264.7 Murine Macrophage and in Liver from Binge Drinking Mice.
Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: February 28, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026